• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成人先天性肾上腺皮质增生症的治疗和健康结局。

Treatment and health outcomes in adults with congenital adrenal hyperplasia.

机构信息

Department of Diabetes and Endocrinology, St Peter's NHS Foundation Trust, Guildford Road, Chertsey, Surrey KT16 0PZ, UK.

BHF Centre for Cardiovascular Science, Queen's Medical Research Institute, University of Edinburgh, 47 Little France Crescent, Edinburgh EH16 4TJ, UK.

出版信息

Nat Rev Endocrinol. 2014 Feb;10(2):115-24. doi: 10.1038/nrendo.2013.239. Epub 2013 Dec 17.

DOI:10.1038/nrendo.2013.239
PMID:24342885
Abstract

Congenital adrenal hyperplasia (CAH) is a genetic disorder caused by defective steroidogenesis that results in glucocorticoid deficiency; the most common underlying mutation is in the gene that encodes 21-hydroxylase. Life-saving glucocorticoid treatment was introduced in the 1950s, and the number of adult patients is now growing; however, no consensus has been reached on the management of CAH beyond childhood. Adult patients are prescribed a variety of glucocorticoids, including hydrocortisone, prednisone, prednisolone, dexamethasone and combinations of these drugs taken in either a circadian or reverse circadian regimen. Despite these personalized treatments, biochemical control of CAH is only achieved in approximately one-third of patients. Some patients have a poor health status, with an increased incidence of obesity and osteoporosis, and impaired fertility and quality of life. The majority of poor health outcomes seem to relate to inadequate treatment rather than the genotype of the patient. Patients receiving high doses of glucocorticoids and the more potent synthetic long-acting glucocorticoids are at an increased risk of obesity, insulin resistance and a reduced quality of life. Further research is required to optimize the treatment of adult patients with CAH and improve health outcomes.

摘要

先天性肾上腺皮质增生症(CAH)是一种由类固醇生成缺陷引起的遗传性疾病,导致糖皮质激素缺乏;最常见的潜在突变是编码 21-羟化酶的基因。20 世纪 50 年代引入了挽救生命的糖皮质激素治疗,现在成年患者的数量正在增加;然而,对于儿童期后 CAH 的管理尚未达成共识。成年患者开的糖皮质激素种类繁多,包括氢化可的松、泼尼松、泼尼松龙、地塞米松以及这些药物的组合,以昼夜节律或反向昼夜节律方案服用。尽管进行了这些个性化治疗,但只有大约三分之一的患者实现了 CAH 的生化控制。一些患者健康状况不佳,肥胖症和骨质疏松症的发病率增加,生育能力和生活质量受损。大多数不良健康结果似乎与治疗不足有关,而不是与患者的基因型有关。接受高剂量糖皮质激素和更有效的合成长效糖皮质激素治疗的患者肥胖、胰岛素抵抗和生活质量下降的风险增加。需要进一步研究以优化 CAH 成年患者的治疗并改善健康结果。

相似文献

1
Treatment and health outcomes in adults with congenital adrenal hyperplasia.成人先天性肾上腺皮质增生症的治疗和健康结局。
Nat Rev Endocrinol. 2014 Feb;10(2):115-24. doi: 10.1038/nrendo.2013.239. Epub 2013 Dec 17.
2
Glucocorticoid replacement regimens for treating congenital adrenal hyperplasia.用于治疗先天性肾上腺皮质增生症的糖皮质激素替代方案。
Cochrane Database Syst Rev. 2020 Mar 19;3(3):CD012517. doi: 10.1002/14651858.CD012517.pub2.
3
Quality of life in adults with congenital adrenal hyperplasia relates to glucocorticoid treatment, adiposity and insulin resistance: United Kingdom Congenital adrenal Hyperplasia Adult Study Executive (CaHASE).成年先天性肾上腺皮质增生症患者的生活质量与糖皮质激素治疗、肥胖和胰岛素抵抗有关:英国先天性肾上腺皮质增生症成人研究执行委员会(CaHASE)。
Eur J Endocrinol. 2013 May 3;168(6):887-93. doi: 10.1530/EJE-13-0128. Print 2013 Jun.
4
Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients.先天性肾上腺皮质增生症成年人的健康状况:203 例患者的队列研究。
J Clin Endocrinol Metab. 2010 Nov;95(11):5110-21. doi: 10.1210/jc.2010-0917. Epub 2010 Aug 18.
5
[Congenital adrenal hyperplasia due to 21-hydroxylase deficiency--management in adults].[21-羟化酶缺乏所致先天性肾上腺皮质增生症——成人的管理]
Endokrynol Pol. 2010;61 Suppl 1:7-21.
6
Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.21-羟化酶缺乏所致经典型先天性肾上腺皮质增生症患儿及青少年中的肥胖问题。
Pediatrics. 2006 Jan;117(1):e98-105. doi: 10.1542/peds.2005-1005.
7
Substitution therapy in adult patients with congenital adrenal hyperplasia.成人先天性肾上腺皮质增生症患者的替代治疗。
Best Pract Res Clin Endocrinol Metab. 2015 Jan;29(1):33-45. doi: 10.1016/j.beem.2014.11.002. Epub 2014 Nov 14.
8
Course of COVID-19 infection in patients with congenital adrenal hyperplasia.COVID-19 感染在先天性肾上腺皮质增生症患者中的病程。
Front Endocrinol (Lausanne). 2024 Feb 9;15:1348130. doi: 10.3389/fendo.2024.1348130. eCollection 2024.
9
Hyperinsulinemic-Euglycemic Clamp Strengthens the Insulin Resistance in Nonclassical Congenital Adrenal Hyperplasia.高胰岛素-正常血糖钳夹术增强非经典型先天性肾上腺皮质增生症的胰岛素抵抗。
J Clin Endocrinol Metab. 2022 Feb 17;107(3):e1106-e1116. doi: 10.1210/clinem/dgab767.
10
Adult consequences of congenital adrenal hyperplasia.先天性肾上腺皮质增生症的成人后果。
Horm Res. 2007;68 Suppl 5:158-64. doi: 10.1159/000110615. Epub 2007 Dec 10.

引用本文的文献

1
Endothelial dysfunction in congenital adrenal hyperplasia due to 21-hydroxylase deficiency: current knowledge and novel biomarkers.21-羟化酶缺乏所致先天性肾上腺皮质增生症中的内皮功能障碍:当前认知与新型生物标志物
Front Endocrinol (Lausanne). 2025 Jun 3;16:1581681. doi: 10.3389/fendo.2025.1581681. eCollection 2025.
2
Modelling adrenal steroid profiles to inform monitoring guidance in congenital adrenal hyperplasia.建立肾上腺类固醇谱模型以指导先天性肾上腺皮质增生症的监测。
EBioMedicine. 2025 Jun;116:105749. doi: 10.1016/j.ebiom.2025.105749. Epub 2025 May 20.
3
Long-term Complications and Testicular Adrenal Rest Tumors in Congenital Adrenal Hyperplasia.

本文引用的文献

1
One hundred years of congenital adrenal hyperplasia in Sweden: a retrospective, population-based cohort study.瑞典 100 年的先天性肾上腺皮质增生症:一项回顾性、基于人群的队列研究。
Lancet Diabetes Endocrinol. 2013 Sep;1(1):35-42. doi: 10.1016/S2213-8587(13)70007-X. Epub 2013 Feb 26.
2
An oral multiparticulate, modified-release, hydrocortisone replacement therapy that provides physiological cortisol exposure.一种口服多颗粒、控释、皮质醇替代治疗药物,可提供生理性皮质醇暴露。
Clin Endocrinol (Oxf). 2014 Apr;80(4):554-561. doi: 10.1111/cen.12316. Epub 2013 Sep 20.
3
Testicular adrenal rest tumors develop independently of long-term disease control: a longitudinal analysis of 50 adult men with congenital adrenal hyperplasia due to classic 21-hydroxylase deficiency.
先天性肾上腺皮质增生症的长期并发症及睾丸肾上腺残余肿瘤
J Clin Res Pediatr Endocrinol. 2025 Jan 10;17(Suppl 1):60-65. doi: 10.4274/jcrpe.galenos.2024.2024-6-22-S. Epub 2024 Dec 23.
4
Reproductive outcomes after antenatal corticosteroids: Secondary analysis of 50-year follow-up of the Auckland steroid randomized trial.产前使用糖皮质激素后的生殖结局:奥克兰糖皮质激素随机试验50年随访的二次分析
Acta Obstet Gynecol Scand. 2024 Dec;103(12):2412-2425. doi: 10.1111/aogs.14984. Epub 2024 Oct 4.
5
Comparison of modified-release hydrocortisone capsules versus prednisolone in the treatment of congenital adrenal hyperplasia.改良释放型氢化可的松胶囊与泼尼松龙治疗先天性肾上腺皮质增生症的比较。
Endocr Connect. 2024 Jul 18;13(8). doi: 10.1530/EC-24-0150. Print 2024 Aug 1.
6
Abiraterone in Classic Congenital Adrenal Hyperplasia: Results of Medical Therapy Before Adrenalectomy.阿比特龙治疗经典型先天性肾上腺皮质增生症:肾上腺切除术前行药物治疗的结果
JCEM Case Rep. 2024 May 24;2(6):luae077. doi: 10.1210/jcemcr/luae077. eCollection 2024 Jun.
7
Depressive and anxiety disorders and antidepressant prescriptions among insured children and young adults with congenital adrenal hyperplasia in the United States.美国保险覆盖的先天性肾上腺皮质增生症患儿和青年中抑郁和焦虑障碍及抗抑郁药物处方情况。
Front Endocrinol (Lausanne). 2023 Aug 17;14:1129584. doi: 10.3389/fendo.2023.1129584. eCollection 2023.
8
Reduced serum concentrations of biomarkers reflecting Leydig and Sertoli cell function in male patients with congenital adrenal hyperplasia.先天性肾上腺皮质增生症男性患者中反映睾丸间质细胞和支持细胞功能的生物标志物血清浓度降低。
Endocr Connect. 2023 Jul 14;12(8):e230073. doi: 10.1530/EC-23-0073.
9
Crinecerfont, a CRF1 Receptor Antagonist, Lowers Adrenal Androgens in Adolescents With Congenital Adrenal Hyperplasia.Crinecerfont,一种 CRF1 受体拮抗剂,可降低先天性肾上腺皮质增生症青少年的肾上腺雄激素。
J Clin Endocrinol Metab. 2023 Oct 18;108(11):2871-2878. doi: 10.1210/clinem/dgad270.
10
Patients with Hypocortisolism Treated with Continuous Subcutaneous Hydrocortisone Infusion (CSHI): An Option for Poorly Controlled Patients.采用皮下持续输注氢化可的松(CSHI)治疗的皮质醇减少症患者:控制不佳患者的一种选择。
Int J Endocrinol. 2023 Mar 20;2023:5315059. doi: 10.1155/2023/5315059. eCollection 2023.
睾丸肾上腺残株肿瘤的发生与长期疾病控制无关:50 例经典 21-羟化酶缺陷导致先天性肾上腺皮质增生症成年男性的纵向分析。
J Clin Endocrinol Metab. 2013 Nov;98(11):E1820-6. doi: 10.1210/jc.2012-3181. Epub 2013 Aug 22.
4
Approach to the patient: the adult with congenital adrenal hyperplasia.患者评估:成人先天性肾上腺皮质增生症。
J Clin Endocrinol Metab. 2013 Jul;98(7):2645-55. doi: 10.1210/jc.2013-1440.
5
Quality of life in adults with congenital adrenal hyperplasia relates to glucocorticoid treatment, adiposity and insulin resistance: United Kingdom Congenital adrenal Hyperplasia Adult Study Executive (CaHASE).成年先天性肾上腺皮质增生症患者的生活质量与糖皮质激素治疗、肥胖和胰岛素抵抗有关:英国先天性肾上腺皮质增生症成人研究执行委员会(CaHASE)。
Eur J Endocrinol. 2013 May 3;168(6):887-93. doi: 10.1530/EJE-13-0128. Print 2013 Jun.
6
Structure-phenotype correlations of human CYP21A2 mutations in congenital adrenal hyperplasia.先天性肾上腺皮质增生症中人类 CYP21A2 突变的结构-表型相关性。
Proc Natl Acad Sci U S A. 2013 Feb 12;110(7):2605-10. doi: 10.1073/pnas.1221133110. Epub 2013 Jan 28.
7
Genotype-phenotype correlation in 1,507 families with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency.21-羟化酶缺陷导致的先天性肾上腺皮质增生症 1507 个家系的基因型-表型相关性。
Proc Natl Acad Sci U S A. 2013 Feb 12;110(7):2611-6. doi: 10.1073/pnas.1300057110. Epub 2013 Jan 28.
8
Genotype-phenotype correlation in 153 adult patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency: analysis of the United Kingdom Congenital adrenal Hyperplasia Adult Study Executive (CaHASE) cohort.21-羟化酶缺陷导致的先天性肾上腺皮质增生症 153 例成人患者的基因型-表型相关性:英国先天性肾上腺皮质增生症成人研究执行委员会(CaHASE)队列分析。
J Clin Endocrinol Metab. 2013 Feb;98(2):E346-54. doi: 10.1210/jc.2012-3343. Epub 2013 Jan 21.
9
What is the best diagnostic and therapeutic management strategy for an Addison patient during pregnancy?妊娠期间 Addison 患者的最佳诊断和治疗管理策略是什么?
Clin Endocrinol (Oxf). 2013 Apr;78(4):497-502. doi: 10.1111/cen.12097.
10
Glucocorticoid treatment regimen and health outcomes in adults with congenital adrenal hyperplasia.糖皮质激素治疗方案与先天性肾上腺皮质增生症成人患者的健康结局。
Clin Endocrinol (Oxf). 2013 Feb;78(2):197-203. doi: 10.1111/cen.12045.